Warning: count(): Parameter must be an array or an object that implements Countable in /home/customer/www/drugtrialsformoney.com/public_html/wp-content/plugins/redux-framework/redux-core/inc/classes/class-redux-output.php on line 394

A Study of BMS-986340 as Monotherapy and in Combination With Nivolumab in Participants With Advanced Solid Tumors

A Study of BMS-986340 as Monotherapy and in Combination With Nivolumab in Participants With Advanced Solid Tumors
Conditions:   Cervical Cancer;   Gastric/Gastroesophageal Junction Adenocarcinoma;   Microsatellite Stable Colorectal Cancer;   Non-Small-Cell Lung Cancer;   Squamous Cell Carcinoma of Head and Neck
Interventions:   Drug: BMS-986340;   Drug: BMS-936558-01
Sponsor:   Bristol-Myers Squibb
**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

June 15, 2021 / by / in
Comments